Oridonin inhibits SASP by blocking p38 and NF-κB pathways in senescent cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oridonin inhibits SASP by blocking p38 and NF-κB pathways in senescent cells
Authors
Keywords
Oridonin, SASP, NF-κB, p38
Journal
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Volume 590, Issue -, Pages 55-62
Publisher
Elsevier BV
Online
2021-12-28
DOI
10.1016/j.bbrc.2021.12.098
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- p21 produces a bioactive secretome that places stressed cells under immunosurveillance
- (2021) Ines Sturmlechner et al. SCIENCE
- Cellular Senescence: Aging, Cancer, and Injury
- (2019) Arianna Calcinotto et al. PHYSIOLOGICAL REVIEWS
- Oridonin inhibits vascular inflammation by blocking NF-κB and MAPK activation
- (2018) Weichen Huang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Oridonin protects against the inflammatory response in diabetic nephropathy by inhibiting the TLR4/p38-MAPK and TLR4/NF-κB signaling pathways
- (2018) Jushuang Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Cadmium-induced IL-6 and IL-8 expression and release from astrocytes are mediated by MAPK and NF-κB pathways
- (2017) Suttinee Phuagkhaopong et al. NEUROTOXICOLOGY
- Oridonin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-induced RAW264.7 cells and acute lung injury
- (2017) Gan Zhao et al. Oncotarget
- Oridonin upregulates PTEN through activating p38 MAPK and inhibits proliferation in human colon cancer cells
- (2016) QIU-XIANG WU et al. ONCOLOGY REPORTS
- Effects of Oridonin on growth performance and oxidative stress in broilers challenged with lipopolysaccharide
- (2016) X. C. Zheng et al. POULTRY SCIENCE
- Oridonin protects HaCaT keratinocytes against hydrogen peroxide-induced oxidative stress by altering microRNA expression
- (2013) SEUNGHEE BAE et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Cellular senescence and the senescent secretory phenotype: therapeutic opportunities
- (2013) Tamara Tchkonia et al. JOURNAL OF CLINICAL INVESTIGATION
- Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK
- (2013) HE-QI BU et al. ONCOLOGY REPORTS
- Oridonin induces apoptosis and senescence by increasing hydrogen peroxide and glutathione depletion in colorectal cancer cells
- (2012) FENG-HOU GAO et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Oridonin enhances antitumor activity of gemcitabine in pancreatic cancer through MAPK-p38 signaling pathway
- (2012) HE-QI BU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Curcumin regulates airway epithelial cell cytokine responses to the pollutant cadmium
- (2011) Jessica Rennolds et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Emerging role of NF-κB signaling in the induction of senescence-associated secretory phenotype (SASP)
- (2011) Antero Salminen et al. CELLULAR SIGNALLING
- p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype
- (2011) Adam Freund et al. EMBO JOURNAL
- Oridonin: An active diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeutics
- (2011) Chun-yang Li et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression
- (2010) Jean-Philippe Coppé et al. Annual Review of Pathology-Mechanisms of Disease
- Oridonin induces apoptosis and senescence in colorectal cancer cells by increasing histone hyperacetylation and regulation of p16, p21, p27 and c-myc
- (2010) Feng-Hou Gao et al. BMC CANCER
- Oridonin induces G2/M arrest and apoptosis via activating ERK–p53 apoptotic pathway and inhibiting PTK–Ras–Raf–JNK survival pathway in murine fibrosarcoma L929 cells
- (2009) Yan Cheng et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started